Amgen Inc. AMGN.TO
TSX
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 37.01B | 36.26B | 35.49B | 35.15B | 34.50B |
| Total Other Revenue | 1.90B | 1.84B | 1.73B | 1.60B | 1.47B |
| Total Revenue | 38.90B | 38.10B | 37.22B | 36.75B | 35.97B |
| Cost of Revenue | 10.71B | 10.67B | 10.59B | 10.70B | 10.73B |
| Gross Profit | 28.19B | 27.43B | 26.63B | 26.05B | 25.24B |
| SG&A Expenses | 6.98B | 7.02B | 6.97B | 7.05B | 6.98B |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 161.00M | 14.00M | -25.00M | 118.00M | 208.00M |
| Total Operating Expenses | 25.69B | 25.33B | 25.03B | 25.14B | 24.77B |
| Operating Income | 13.21B | 12.77B | 12.19B | 11.61B | 11.20B |
| Income Before Tax | 11.05B | 10.29B | 9.09B | 8.98B | 8.24B |
| Income Tax Expenses | 1.66B | 1.54B | 1.29B | 1.27B | 1.24B |
| Earnings from Continuing Operations | 9.39K | 8.74K | 7.80K | 7.71K | 7.01K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 9.39B | 8.74B | 7.80B | 7.71B | 7.01B |
| EBIT | 13.21B | 12.77B | 12.19B | 11.61B | 11.20B |
| EBITDA | 17.57B | 17.31B | 16.96B | 16.66B | 16.52B |
| EPS Basic | 17.38 | 16.22 | 14.48 | 14.33 | 13.02 |
| Normalized Basic EPS | 12.87 | 12.35 | 11.56 | 10.35 | 9.68 |
| EPS Diluted | 17.25 | 16.10 | 14.38 | 14.24 | 12.94 |
| Normalized Diluted EPS | 12.77 | 12.26 | 11.48 | 10.29 | 9.61 |
| Average Basic Shares Outstanding | 2.16B | 2.16B | 2.16B | 2.15B | 2.15B |
| Average Diluted Shares Outstanding | 2.18B | 2.17B | 2.17B | 2.17B | 2.17B |
| Dividend Per Share | 9.94 | 9.80 | 9.66 | 9.52 | 9.39 |
| Payout Ratio | 57.14% | 60.45% | 66.71% | 66.45% | 72.03% |